Thursday, May 4, 2023

LOL, Moderna's surprise quarterly profit plunged 97% per share amid collapsing vaccine demand, comes from Covid shot revenue deferred from 2022, first quarter sales tank 69%, CNBC says 30%

CNBC, here:

Moderna on Thursday blew past estimates for first-quarter earnings and revenue, posting a surprise quarterly profit, despite lower demand for Covid vaccines, its only marketable product.

The biotech company generated first-quarter sales of $1.9 billion, driven by Covid shot revenue deferred from 2022. That’s down more than 30% from the $6.1 billion it recorded in the same period a year ago amid a resurgence of Covid cases.

Moderna posted net income of $79 million, or 19 cents per share, for the quarter. That’s compared with $3.66 billion in net income, or $8.58 per share, reported during the same quarter last year.

Seeking Alpha got it right, noting the inventory write-downs of "excess and obsolete COVID-19 products" nobody wants:

 


I'll just put this here for the record in the event CNBC later corrects their reporting without saying so: